Dudediligence.

DBV Technologies S.A.

DBVTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.1MSep ’24$511,000Dec ’24$800,000Mar ’25$1.5MJun ’25$2.8MSep ’25$645,000Dec ’25$900,000Mar ’26$700,000Jun ’26
Net income, by quarter
−$30.4MSep ’24−$23.0MDec ’24−$27.1MMar ’25−$41.9MJun ’25−$33.2MSep ’25−$44.8MDec ’25−$47.6MMar ’26−$50.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$5.7M$4.8M$15.7M$4.2M$5.6M
Operating income−$98.6M−$96.6M−$76.4M−$116.6M−$147.1M
Net income−$97.8M−$96.3M−$72.7M−$113.9M−$146.9M
Operating cash flow−$108.2M−$55.7M−$79.7M−$104.5M−$121.2M
Free cash flow−$109.2M−$56.4M−$80.3M−$106.8M−$121.7M
Cash$77.3M$209.2M$141.4M$32.5M$194.2M
Debt$510,000none on filenone on filenone on filenone on file
Shares outstanding54.9M77.4M96.4M102.8M235.7M